VJHemOnc is committed to improving our service to you

VJVirtual | New therapies for MPNs

VJHemOnc is committed to improving our service to you

Jean-Jacques Kiladjian

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, explores emerging therapies for patients with myelofibrosis including pacritinib and momelotinib, JAK kinase inhibitors, as well as other agents therapies being investigated as single agents or as part of combined approaches. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter